DNA macroarray analysis of gene expression changes in rat brain after single administration of 2-aminoadamantane compound

Molekulyarnaya Biologiya

Volumn 39, Issue 2, 2005, Pages 276-285

  Vakhitova, J V ^a,b   Yamidanov, R S ^b   Vakhitov, V A ^b   Seredenin, S B ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

2 ADAMANTANAMINE; ACTIN; ADAMANTANE DERIVATIVE; APC PROTEIN; COMPLEMENTARY DNA; CYTOSKELETON PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN GAPDH; PROTEIN KINASE C; PROTEIN NSE; PROTEIN PMCA; PROTEIN TUBALPHA1; RETINOBLASTOMA PROTEIN; SYNAPTIC PROTEIN 1A; SYNAPTIC PROTEIN 1B; UNCLASSIFIED DRUG; 2-AMINOADAMANTANE; AMANTADINE; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CARBH GENE; CONTROLLED STUDY; DNA DETERMINATION; DRUG ACTIVITY; GAT3 GENE; GENE; GENE EXPRESSION; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANQUILIZING ACTIVITY; ANIMAL; BRAIN; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; METABOLISM;

AMANTADINE; ANIMALS; BRAIN; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS;

EID: 20844439878     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Guang Ch., Khondakar A., Hasanat A., Bebchuk J.M., Moore G., Clitz D., Manji H.K. 1999. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosomatic Med. 61, 599-617.
2. Applied Biosystems, ABI PRISM 7700 Sequence Detection System, User Bulletin #2, 2001, 36 p.
3. Pfaffl M.W. 2001. A new mathematical model for relative guantification in real-time RT-PCR. Nucleic Acids Res. 29, E45.
4. Freeman W.M., Robertson D.J., Vrana K.E. 2000. Cronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression. Biotechniques. 29, 1042-1055.
5. Freeman W.M., Brebner K., Lynch W.J., Palet K.M., Robertson D.J., Roberts D.C.S., Vrana K.E. 2002. Changes in rat frontal cortex gene expression following chronic cocaine. Mol. Brain Res. 104, 11-20.
6. Sokolov B.P., Polesskaya O.O., Uhl G.R. 2003. Mouse brain gene expression changes after acute and chronic amphetamine. J. Neurochem. 84, 244-252.
7. Jayanthi S., McCoy M.T., Ladenheim B., Cadet J.L. 2002. Methamphetamine causes coordinate regulation of Src, Cas, Crk and Jun N-terminal kinase-Jun pathway. Mol. Pharmacol. 61, 1124-1131.
8. Freeman W.M., Brebner K., Lynch W.J., Robertson D.J., Roberts D.C.S., Vrana K.E. 2001. Cocaine-responsive gene expression changes in rat hippocampus J. Neurosci. 108, 371-380.
9. Dringen R., Gebhardt R., Hamprecht B. 1993. Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain Res. 623, 208-214.
10. Marangos P.J., Schmechel D.E. 1987. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu. Rev. Neurosci. 10, 269-295.
11. Hattori T., Takei N., Mizuno Y., Kato K., Kohsaka S. 1995. Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci. Res. 21, 191-198.
12. Dastoor Z., Dreyer J.L. 2001. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J. Cell Sci. 114, 1643-1653.
13. Allaman I., Pellrin L., Magistrelli P.J. 2000. Protein targeting to glycogen (PTG) mRNA expression is stimulated by noradrenaline in mouse cortical astrocytes. Glia. 30, 282-391.
14. Akil H., Owens C., Gutstein H. 1998. Endogenous opioids: overview and carrent issues Drug Alcohol. Depend. 51, 127-140.
15. Kiefler B.L. 1995. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15, 615-634.
16. Hook V.Y.H., LaGamma E.F. 1987. Product inhibition of carboxypeptidase H. J. Biol. Chem. 262, 12583-12588.
17. Rodriguez C., Braybon K.A., Brownstein M., Dixon J.E. 1984. Rat preprocarboxypeptidase H. Cloning, characterization, and sequence of the cDNA and regulation of the mRNA by corticotropin-releasing factor. J. Biol. Chem. 264, 5988-5995.
18. Berke J.D., Paletzki R.F., Aronson G.J., Hyman S.E., Gerfen C.R. 1998. A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci. 18, 5301-5310.
19. Masson J., Sagne C., Hamon M., Mestikawys E. 1999. Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51, 439-464.
20. Peng W., Simantov R. 2003. Altered gene expression in frontal cortex and midbrain of 3,4-methylene-dioxymethamphetamine (MDMA) treated mice: differental regulation of GABA transporter subtypes. J. Neurosci. Res. 72, 250-258.
21. Ito C. 2002. Analysis of overall gene expression induced by amphetamine and phencyclidine: novel targets for the treatment of drug psychosis and schizophrenia. Current Pharmaceut. Design. 8, 147-153.
22. Boggs J.M., Mosarello M.A. 1978. Structural organization of the human myelin membrane. Biochim. Biophys. Acta. 515, 1-21.
23. MacMillan S.V., Ishiyma N., White G.F., Palaniyar N., Hallett F.R., Harauz G. 2000. Myelin basic protein component C1 in increasing concentrations can elicit fusion, aggregation, and fragmentation of myelin-like membranes. Eur. J. Cell Biol. 79, 327-335.
24. Kaplan M.R., Meyer-Franke A., Lambert S., Bennett V., Duncan I.D., Levinson S.R., Barres B.A. 1997. Induction of sodium channel clustering by oligodendrocytes. Nature. 386, 724-728.
25. Greengard P., Valtorta F., Czernik A.J., Benfenati F. 1993. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science. 259, 780-785.
26. Thiriet N., Ladenheim B., McCoy M.T., Cadet J.L. 2002. Analysis of Ecstasy (MDMA)-induced transcriptional responsis in the rat cortex. FASEB J. 16, 1887-1894.
27. Wong M.-L., O'Kirwan F., Hannestad J.P., Irizarry K.J.L., Elashoff D., Licinio J. 2004. St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol. Psych. 9, 237-251.
28. Noailles D.A., Becher K.G., Wood W.H., Teichberg D., Cadet J.L. 2003. Methamphetamine-induced gene expression profiles in the striatum of male rat pups exposed to the drug in utero. Brain Res. Dev. Brain Res. 147, 153-162.
29. Yaffe M.B. 2002. How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513, 53-57.
30. Carafoli E. 2002. Calcium signaling: A tale for all seasons. Proc. Natl. Acad. Sci. USA. 99, 1115-1122.